Last updated on January 2019

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors

Brief description of study

The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standard-dose proton pump inhibitors (PPIs).

Clinical Study Identifier: NCT03561090

Find a site near you

Start Over

IMA Medical Research, PC.

Kew Gardens, NY United States
  Connect »

NYU School of Medicine

Great Neck, NY United States
  Connect »

Weill Cornell Medical College

New York, NY United States
  Connect »

Manhattan Medical Research Practice PLLC

New York, NY United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.